Analysis: The rollout of Covid-19 vaccines in the Middle East is being driven by diplomatic considerations, with China, Russia and the United States all competing for influence. As demand for vaccines surges across the Middle East and North Africa, China and Russia have seen an opportunity to push their own products as a diplomatic tool in the region, in competition with the United States. Beijing's production of its own vaccines, through its companies Sinopharm and Sinovac, aims to further its Covid-19 diplomacy and act as a counterweight to Western alternatives, including the US-based Moderna vaccine, the German American company Pfizer and the British-Dutch Oxford-AstraZeneca vaccine.
Hence then, the article about the geopolitics of vaccine diplomacy in the middle east was published today ( ) and is available onThe New Arab ( Kuwait ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The geopolitics of vaccine diplomacy in the Middle East )